Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Modern Pharmaceutical Formulation Engineering Research Center is a specialized R&D subsidiary of Shanghai Modern Pharmaceutical, a member of the China National Pharmaceutical Group (Sinopharm). The center serves as a national-level engineering hub focused on the development and industrialization of advanced drug delivery systems (DDS). Its core expertise includes the design of sustained-release, controlled-release, and targeted oral formulations for small molecule therapeutics. Beyond internal R&D, the center provides technical services such as formulation optimization and consistency evaluation for generic drugs to meet international standards. It has successfully commercialized numerous products in the cardiovascular, anti-infective, and metabolic therapeutic areas. The facility bridges the gap between laboratory-scale pharmaceutical research and large-scale industrial production within the Sinopharm ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Modern Pharmaceutical Formulation Engineering Research Center.